EMPIRE-CF: A phase II randomized placebo-controlled trial of once-daily, oral acebilustat in adult patients with cystic fibrosis - Study design and patient demographics. - Elborn JS; Ahuja S; Springman E; Mershon J; Grosswald R; Rowe SM (Contemporary clinical trials, 2018)